Reproductive Genetics Market Applications, Countries, Size, Forecast to 2028


Emerging research

The global reproductive genetics market size is expected to reach USD 11.23 billion at a stable CAGR of 12.3% in 2028

SURREY, BRITISH COLUMBIA, CANADA, March 29, 2022 / — The latest market information report titled “Global Reproductive Genetics Market” aims to provide the target audience with necessary information about the global reproductive genetics industry. The report encompasses a detailed analysis of the vital elements of the Reproductive Genetics market, including key drivers, restraints, opportunities, limitations, threats, and micro and macroeconomic factors. The report carefully examines the current market scenario and fundamental growth prospects. The report includes an organized database of Reproductive Genetics market dynamics that helps market analysts to estimate the growth rate of the global market over the projected period. Hence, the report, published by emergenresearch, is a detailed compilation of crucial aspects of the Reproductive Genetics market, including major players’ product offerings, wide range of applications of these products, major segments of market, key market competitors, their company profiles, pricing strategies, production capacities, revenue generating programs, technological advancements and many more

Increased investment from large corporations and growing demand for genetic testing, as well as improved reimbursement policies for medical testing are key growth drivers

Reproductive Genetics Market Size – USD 4.41 billion in 2020, Market Growth – at a CAGR of 12.3%, Market Trends – Rising demand for in vitro fertilization procedures

Get a sample of the report:

Market scope:

One of the central elements of the report is the broad segmentation of the Reproductive Genetics market which includes range of product types, spectrum of applications, end-user industry landscape, important geographical regions and the main competitors in the market. The financial positions of key players, along with their gross profit, sales volume, sales revenue, manufacturing cost, and other financial ratios, have been accurately assessed in the report. In addition, several analytical tools such as investment assessment, SWOT analysis and Porter’s five forces analysis have been implemented by our analyst team to assess the production and distribution capabilities of players in the reproductive genetics market.

Major market players include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen NV, and OPKO Health, Inc.

Chromosomal abnormalities are responsible for 50% of first trimester miscarriages. Reproductive genetics identifies embryos without these abnormalities so they can be used for IVF, increasing the likelihood of a healthy pregnancy and baby, regardless of the health of the patient. It also helps to achieve higher pregnancy rates per transfer, reducing the need for IVF and resulting in low cost, time and stress.

Advances in genomic technologies and the implementation of these technologies in clinical medicine have expanded their use in the diagnosis of genetic disorders, carrier screening, and identification of the cause of infertility. Some tests are quite expensive, which deters couples from going ahead with testing, but as there is a drop in the cost of sequencing and an increase in the mixed ethnic population, it is expected that an increasing number of couples/individuals are opting for the procedure and this is expected to support the growth of the market in the future.

Prenatal screening covers a variety of tests that doctors recommend for a pregnant patient. Some prenatal screening tests determine whether or not a baby has chromosomal disorders, such as Down syndrome. Although recommended by doctors, it is non-invasive and optional, and poses no risk to pregnancy as it involves ultrasound and blood tests.

Next-generation sequencing (NGS) is a widely accepted genetic testing technology in the field of prenatal testing. NGS is able to detect embryos with unbalanced chromosomal translocations that have not been identified before. NGS offers better chromosome coverage, higher resolution, and is faster and more affordable.

Monogenic diseases are among the best understood genetic diseases due to their relatively simple modes of transmission and genetic causes. Some of the most common monogenic diseases are sickle cell disease, hemochromatosis, cystic fibrosis, and Tay-Sachs. Reproductive genetic testing is done to detect the possibility of single gene disorders in babies.

Request a discount on the report:

Asia-Pacific market revenue is expected to register a rapid CAGR during the forecast period owing to the growing demand for genetic testing from India and China. Additionally, increased usage of IVF procedures and advancements in the healthcare industry are major factors driving the market growth in the region.

Table of Content of Global Reproductive Genetics Market Report:

Chapter 1 describes Reproductive Genetics introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.

Chapter 2 analyzes the major manufacturers of Reproductive Genetics and the sales, revenue and price of Reproductive Genetics during the forecast period.

Chapter 3 studies the competitive situation among key manufacturers and suppliers, with the sales, revenue and market share.

Chapter 4 analyzes the global market by regions, with the Reproductive Genetics sales, revenue and market share, for each region, from 2020 to 2027.

Chapter 5, 6, 7, 8, and 9 analyze the Reproductive Genetics market by type, application, regions and manufacturers, with sales, revenue and market share by key countries in these regions… Continued

Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

Laboratory Developed Tests (LDT)


Reagents and Consumables

Procedural Type Outlook (Revenue, USD Billion; 2018-2028)

Prenatal screening

Pre-implantation genetic test

Genetic test for infertility

Carrier screening

Technology Outlook (Revenue, USD Billion; 2018-2028)

Next Generation Sequencing (NGS)


Polymerase chain reaction (PCR)

In situ hybridization (ISH)

Application Outlook (Revenue, USD Billion; 2018-2028)

Monogenic disorder


Structural chromosomal abnormality


Key Points of the Reproductive Genetics Market:

Extensive Coverage of Reproductive Genetics Market Analysis

Key information on the regional breakdown of the industry in key geographies

Sweeping insights into vital market trends; current and emerging trends, and factors influencing market growth

Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Reproductive Genetics Market

Comprehensive data on major manufacturers and suppliers of Reproductive Genetics Market

Learn more:

Related reports:

Patient Engagement Solutions Market:

Nucleic Acid Isolation and Purification Market:

Non-Invasive Prenatal Testing Market:

RNA Transcriptomics Market:

Blockchain in Healthcare:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.

Contact us:

Eric Lee

Corporate Sales Specialist

Emerging research | Web:

Direct Line: +1 (604) 757-9756

Email: [email protected]

Facebook | LinkedIn | Twitter | Blogs

Eric Lee
Emerging research
+91 90210 91709
write to us here
Visit us on social media:


Comments are closed.